Email Print this page Bookmark this page

Contact Us

Valeant is committed to making itself available to LACRISERT® users and eye care professionals alike.

If you need to speak with a Valeant representative, regarding a LACRISERT® prescription, please contact us directly at:

Valeant Patient Assistance Program

866-268-7325
Monday-Friday, 9am-5 pm (except holidays)

E-mail Contacts

US Medical Information: druginfo@medcomsol.com

Please note: Only an eye care professional can provide one-on-one treatment and advice, regarding a particular case of Dry Eye.

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Rebate Dr Find using Lacrisert video Dry Eye Symptoms Survey, Take Survey Now Instant coupon: up to $60 in savings
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807